C
CARB-X
AcceleratorActiveCARB-X is a biopharmaceutical business enterprise that specializes in biotechnology, antibiotics, vaccines, fast diagnostics.
28
Investments
6
Exits
—
AUM
21.4%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for CARB-X.
Investment Thesis & Strategy
CARB-X invests in various stages of biotechnology companies focused on antibiotics, vaccines, and fast diagnostics. They seek to accelerate the development of products in the biopharmaceutical industry.
Investment Activity
Deals per year over the last 9 years
3
20100
20110
20121
20132
20142
20153
20160
20171
2018Portfolio Companies
Selected investments from their portfolio of 28 companies
B
Bugworks Research
Biotech · Series A, 2018
I
Iterum Therapeutics
Biotech · Series A, 2016
V
Venatorx Pharmaceuticals
Biotech · Series A, 2016
B
BioVersys
Biotech · Series A, 2016
E
Entasis Therapeutics
Biotech · Series A, 2015
F
F2G
Biotech · Series A, 2015
S
Spero Therapeutics
Biotech · Series A, 2014
C
Cidara Therapeutics
Biotech · Series A, 2014
M
Melinta Therapeutics
Biotech · Series A, 2013
A
Achaogen
Biotech · Series A, 2010
C
ContraFect
Biotech · Series A, 2010
T
The Medicines Company
Biotech · Series A, 2010
Frequently Asked Questions
CARB-X focuses on Pre-seed, Seed stage investments.
Related Investors
Techstars Boston Accelerator
Boston, United States · 193 deals
IDEA Northeastern University's Venture Accelerator
Boston, United States · 98 deals
LearnLaunch Accelerator
Boston, United States · 73 deals
Summer@Highland
Boston, United States · 50 deals
FinTech Sandbox
Boston, United States · 49 deals
AcceliCITY
Boston, United States · 21 deals